TEVA compared with AMRX: revenue, margins and what each company keeps, and the suppliers and customers both name

TEVATeva Pharmaceutical Industries Ltd

Mkt capRevenueRevenue

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

TEVATeva Pharmaceutical Industries Ltd

AMRXAmneal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 499dMethod ›

Moved together

TEVAwithAMRX

×0.30co-movement · AMRX on TEVA · 499d

r 0.39scale to r 0.75

Shared co-movers2with TEVAwith AMRX

INDVIndivior Pharmaceuticals, Inc.r 0.38r 0.43

VTRSViatris Incr 0.32r 0.44

TEVA, solidAMRX, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

TEVATeva Pharmaceutical Industries Ltd

42.09▲+1.50%· post 41.97

Mkt cap$49.0BRevenue$4.1BQ2 FY26Revenue$17.3BFY25

AMRXAmneal Pharmaceuticals, Inc.

21.50▲+0.70%· post 21.43

ClosedOct 30 '26

Mkt cap$6.9BRevenue$796MQ2 FY26Revenue$3.0BFY25

Compare

ClosedOct 30 '26

TEVATeva Pharmaceutical Industries Ltd

AMRXAmneal Pharmaceuticals, Inc.

42.09▲+1.50%post 41.97

Price

21.50▲+0.70%post 21.43

$49.0B

Mkt cap

$6.9B

Q2 FY26$4.1B

Revenue

$796MQ2 FY26

FY25$17.3B

Revenue

$3.0BFY25

TEVA42.09▲+1.50%vsAMRX21.50▲+0.70%ClosedOct 30 '26